News | January 31, 2023
Alkem to launch novel antibiotic for MDR infections
Zidavi is recommended by the Infectious Disease Society of America
Zidavi is recommended by the Infectious Disease Society of America
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
40,000 visitors and representatives of more than 80 countries set to visit the show
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Subscribe To Our Newsletter & Stay Updated
